How enclomiphene raises testosterone through your own axis: who it works for, the 12.5 mg protocol, the E2 sweet spot, and the bloodwork that decides it.
40 min read
The Enclomiphene File is a mechanism-first, bloodwork-driven reference on enclomiphene monotherapy for secondary hypogonadism — the exact panels, doses and response curves that decide whether it is working. Enclomiphene raises your own testosterone by removing the estrogen brake at the hypothalamus, so LH and FSH climb and the testes produce more testosterone, with the axis never shut down. That is what separates it from testosterone replacement: it works only through your own system, which is why testicular volume, fertility and the ability to come off it are all preserved. This is educational content, not medical advice or a licence to self-prescribe: enclomiphene is a prescription medication, every dose here is drawn from published clinical literature, and every decision belongs with a physician and a lab result in your hand.
What's Inside
Written for men with symptomatic secondary hypogonadism — low or normal LH with low testosterone and working testes — who want to raise testosterone while keeping fertility and testicular function, and who will run it under a physician with sensitive-assay bloodwork. It assumes you can read a hormone panel, calculate free testosterone, and act on numbers rather than mood. It is not for men with primary hypogonadism or high LH, not a licence to self-prescribe, and not for tested athletes, since enclomiphene is banned year-round under WADA Section S4.
Enclomiphene is the trans-isomer of clomiphene citrate. Old clomid was always two drugs in one bottle: enclomiphene, the estrogen antagonist with a roughly 10-hour half-life, and zuclomiphene, an estrogen agonist with a ~30-day half-life that accumulated and drove clomid's mood and vision reputation. Isolating the trans-isomer removes that agonist tail. As a selective estrogen receptor modulator it blocks the estrogen alpha receptor at the hypothalamus, so the brain stops seeing estrogen, pushes the GnRH pulse higher, and LH and FSH rise to drive the Leydig cells. Withdraw it and the axis returns to baseline within two to four weeks. The honest marker throughout is LH — it cannot be faked from outside, and total testosterone rising without LH rising is not enclomiphene working, it is something else. Before spending anything on it, the guide has you run a baseline through the Bloodwork Analyzer to confirm which category you are in.
Only men with secondary hypogonadism whose testes still work — it is a single-mechanism drug that removes the estrogen brake and does nothing else, so if the problem is downstream it cannot help. The guide's one-line rule: if your LH is low and your testes work, enclomiphene is almost always the better answer; if your LH is high or your testes are damaged, it cannot help you. Five gates must all pass — secondary (not primary) hypogonadism, controlled prolactin, an estradiol that has not already been crashed by a prior AI or cycle, and adequate pituitary reserve — filtered against a 22-marker baseline panel drawn fasted before 09:00. Against exogenous TRT it keeps LH and FSH elevated, maintains testicular volume and intratesticular testosterone, preserves fertility, is oral once daily, and restarts in two to four weeks on exit rather than three to twelve months. The Blood Test Selector builds that baseline panel and flags the reproductive markers standard packages leave out, and because untreated thyroid trouble masks the response, the Thyroid Assessment Engine reads that pattern first.
12.5 mg daily with breakfast, run continuously for twelve weeks, with the decision made from bloodwork rather than mood — this is the Wiehle Phase II dose where most responders land. There is no evidence that doses above 25 mg add benefit; the SHBG response saturates and more only buys side effects. The single biggest read error is the SHBG trap: enclomiphene reliably raises SHBG, so total testosterone can double from 400 to 780 while free testosterone — the fraction that actually works — barely moves from 8 to 10. Always read the direct free testosterone, calculated from the Vermeulen equation using an LC-MS/MS total T and a direct SHBG, not the headline total. The other classic self-inflicted failure is the estradiol crash: enclomiphene raises E2 modestly because total testosterone is up, which is expected, and the sweet spot where libido, mood, joints, lipids and bone all sit right is 30 to 40 pg/mL on a sensitive assay. Below 20 is where men destroy their own run, usually by panicking at a 48 reading and reaching for an aromatase inhibitor. The Estrogen / AI Dose Calculator models the drop before you swallow anything, so a number that needs no action does not get one.
No — enclomiphene is itself a PCT mechanism, so the honest exit is a two-week taper at 12.5 mg every other day rather than a second drug on top. It clears in three to four days, the axis returns to its pre-enclomiphene baseline over two to four weeks, and a full recovery panel at week four confirms it: LH and FSH within 20 percent of your original baseline is a full restart, while LH now well below baseline means the drug was masking something a physician needs to see. This is the reverse of a suppressive compound — there is no exogenous hormone to clear and no shutdown to recover from — which is the whole point of choosing it. For men coming off an actual suppressive cycle rather than an enclomiphene block, muscle-preserving recovery is covered in The Last Hold, and the fertility physiology enclomiphene protects is covered in full in The Legacy Keeper.
For the right man, yes — but it is a different tool, not a moral upgrade. Enclomiphene only works for secondary hypogonadism, where the brain's signal is weak but the testes still respond. In that case it beats TRT on the things TRT costs you: it keeps LH and FSH elevated, maintains testicular volume and intratesticular testosterone, preserves fertility, is oral once daily, and restarts in two to four weeks instead of three to twelve months. If your LH is already high, your problem is testicular, and enclomiphene cannot help — TRT is the honest answer there.
Almost always the SHBG trap. Enclomiphene reliably raises SHBG, and total testosterone can double while free testosterone — the fraction that actually reaches tissue — barely moves. A total T that went 400 to 780 looks like success, but if SHBG rose from 25 to 40 over the same window, free T only went from 8 to 10, and that is where symptoms live. Draw a direct free testosterone by equilibrium dialysis plus SHBG and calculate free T from the Vermeulen equation. That number matches how you feel, not the headline total.
Almost never, and the reflex to add one kills more enclomiphene runs than any side effect. Enclomiphene raises estradiol modestly because testosterone is up — that is expected, and the sweet spot is 30 to 40 pg/mL on a sensitive assay, where libido, mood, joints, lipids and bone all sit right. A man who sees E2 hit 48, panics, takes 0.5 mg anastrozole and lands at 12 will lose his libido and blame the enclomiphene. An AI is only a conversation when E2 is genuinely high and there are symptoms, and then only a physician-directed microdose.
No — it is a support formula, not a testosterone, and the guide places it in Tier 3 of the supplement pyramid, below the lifestyle floor and the foundational micronutrients. It stacks the actives with the best hypogonadism data, like Tongkat Ali and KSM-66 ashwagandha, at dosed amounts alongside the zinc, boron and D3 you would otherwise buy separately, so it earns its place as convenience. It will do nothing for a man whose enclomiphene or lifestyle floor is not in place, nothing for primary hypogonadism, and it duplicates your stack if you already supplement those micronutrients individually. The guide grades every ingredient honestly, including the weak ones. See the range at godofsupps.com.
This guide is for educational purposes only and is not medical advice.
Newsletter
One email when a new guide, calculator or breakdown goes live. Nothing else.
